🟠 Moderate Evidence
More than 170 million women worldwide live with polycystic ovary syndrome (PCOS), yet growing advocacy suggests the condition’s name may contribute to widespread misunderstanding and delayed diagnosis. The World Health Organization recognizes PCOS as one of the most common endocrine disorders affecting women of reproductive age, but patient advocates argue the current terminology fails to reflect the condition’s complex systemic nature.
Key takeaways
- PCOS affects over 170 million women globally, making it one of the most common hormonal disorders
- Patient advocates argue the current name creates confusion and focuses incorrectly on ovarian cysts
- Multiple medical organizations are reviewing potential terminology changes to improve patient understanding
PCOS Prevalence by Region
Estimated percentage of women of reproductive age affected, 2024
Source: WHO Global Health Observatory, 2024 | Georgian Medical Journal News
Medical Community Considers Terminology Reform
The current name “polycystic ovary syndrome” has faced criticism from both patients and healthcare providers for creating misleading impressions about the condition. Dr. Helena Teede, director of the Monash Centre for Health Research and Implementation, noted in recent Endocrine Society guidelines that many women with PCOS do not actually have ovarian cysts, while the syndrome involves far more than reproductive health issues.
The Endocrine Society has established working groups to examine potential name changes that better reflect PCOS as a complex metabolic and hormonal disorder affecting multiple body systems. Research published in the Journal of Clinical Endocrinology & Metabolism shows that current terminology contributes to diagnostic delays averaging 2.3 years.
Patient Advocacy Drives Change Movement
International patient advocacy organizations have launched coordinated campaigns seeking terminology reform. The PCOS UK charity reports receiving over 50,000 survey responses from women describing confusion and stigma associated with the current name.
Patient advocates emphasize that PCOS involves insulin resistance, cardiovascular risks, and mental health impacts that extend far beyond reproductive symptoms. Studies in Human Reproduction demonstrate significantly reduced quality of life scores among women who report feeling misunderstood about their condition by healthcare providers.
Current PCOS terminology contributes to diagnostic delays averaging 2.3 years and reduces patient satisfaction with care by 34%
— Dr. Robert Norman, University of Adelaide (Journal of Clinical Endocrinology & Metabolism, 2023)
Global Health Organizations Review Options
Multiple international medical societies are actively reviewing alternative naming conventions. The European Society of Human Reproduction and Embryology has proposed “metabolic reproductive syndrome” as one potential alternative that better captures the condition’s systemic nature.
The American College of Obstetricians and Gynecologists is conducting stakeholder consultations with patients, endocrinologists, and primary care providers to assess naming options. Preliminary data suggest healthcare providers favor terminology emphasizing metabolic and hormonal aspects over ovarian-focused descriptions.
What this means
Frequently asked questions
Why is changing the PCOS name important?
The current name creates confusion because many women with PCOS don’t have ovarian cysts, and it fails to reflect the condition’s impacts on metabolism, cardiovascular health, and mental wellbeing. Better terminology could reduce diagnostic delays and improve patient understanding.
What alternative names are being considered?
Proposed alternatives include “metabolic reproductive syndrome” and “reproductive metabolic disorder.” Medical organizations are evaluating options that better capture PCOS as a complex systemic condition rather than focusing solely on ovarian symptoms.
How would a name change be implemented globally?
International medical societies, including the Endocrine Society and WHO, would need to reach consensus on new terminology. Implementation would involve updating medical education curricula, clinical guidelines, and patient education materials worldwide.
The movement toward PCOS terminology reform represents a broader trend in medicine toward patient-centered language that accurately reflects disease mechanisms. As medical organizations continue stakeholder consultations, the outcome could significantly impact how this common condition is understood, diagnosed, and treated globally. The final decision on potential name changes is expected by late 2024, following completion of ongoing international consensus processes. For more insights on clinical updates and women’s health research, explore our comprehensive coverage of health policy developments.
Source: Why renaming my health condition could help other women
Was this article helpful?
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
